Google's AI Strategy, Microsoft's BitNet b1.58, and OpenAI's New Safety System

In this episode, Michelle delves into Google's strategic ambitions in the AI sector, providing insight into their long-term vision. She then explores Microsoft's unveiling of BitNet b1.58 2B4T, discussing its potential impact on the industry. The conversation shifts to Isomorphic Labs and their pioneering AI-first approach to drug discovery, which could revolutionize the pharmaceutical landscape. Additionally, Michelle covers OpenAI's introduction of a new safety system designed to enhance the security of AI models. The episode wraps up with concluding thoughts on these developments and their implications for the future of artificial intelligence. (0:00) Introduction to Google's AI ambitions and strategy (2:08) Microsoft unveils BitNet b1.58 2B4T and its potential (5:08) Isomorphic Labs' AI-first approach to drug discovery (7:14) OpenAI's new safety system for AI models (9:42) Conclusion and sign-off